Contemporary ALL Therapy and What is on the Horizon
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and has excellent survival rates. However, outcomes for patients who relapse are poor and ALL…
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and has excellent survival rates. However, outcomes for patients who relapse are poor and ALL…
**By selecting “Yes”, you consent to receive information from CHOP. Once you have decided to receive such communications, you may later decide to stop receiving these communications. If you want to stop receiving these communications, you may send an email message to chopopensupport@chop.edu.